Consulting with Pharmaceutical Companies to improve commercial effectiveness.

Achieved YOY growth of 60% for Analytical Wizards, positioning for acquisition
Led integration and collaboration with Definitive Healthcare post-acquisition
Developed winning strategy and executed full funnel tactics to create awareness, value and drive acquisition

-Change management lead on multiple internal projects, including Helsinn Alliance and Merck Alliance
-Chief of Staff to President of Eisai and SVP of Oncology guiding Oncology group through 5 leadership changes in two years team growth
-Change management lead for sales force revamp that included changing all rolls, territory realignments, and targets, competencies, IC and KPIs, and reports
-Led Commercial Leadership Team, created and adapted new processes, frameworks and hub of operations. Created templates and ongoing reports; employed servant leadership, coach and mentor strategies
-Launch Planning leader across Oncology Business Groups
-Led Speaker Bureau Revamp Project requiring change management principles across the Enterprise and stakeholders
-Led all National Sales Meetings and ASCO Strategy, including new roadmap for ASCO
-Built new MarCom Function with 2 direct reports to facilitate launch efficiencies and success

-Completely rebranded agency with values, goals, and organizational design
-Established new efficiencies, reducing redundancies and achieving 39% new business growth
-Recruited new talent and incorporated employee reward systems

-Strategic Lead for Genentech's TARCEVA and BioOncology Patient Marketing Agency of Record business at Flashpoint Medica, overseeing $8M+ revenue with 6 direct reports
-Strategic Lead for Merck's ZETIA/VYTORIN US and Global Franchise for CAHG with 6 direct report and $9M+ revenue; led global oncology pitch to Boerhinger Ingelheim

- Transition and change management leader for Oncology Business Group
- Realignment and organizational structure to create new unit and win new business
- Managed through the Medarex/BMS Alliance as agency of record strategy lead for ipilimumab (YERVOY), providing strategy recommendations to global leader and label committee in launch the Immuno-Oncolgy Franchise
- Worked with GSK and employed Agile techniques and Scrum workshops

- US and Global lead for Genentech and Roche's AVASTIN Franchise
- Rebranding for the Breast Cancer global approval required extensive change management in the really days of the alliance
- Significant and fast growth in agency team from four to twenty-one account people also lead to employ change management initiatives to deliver the highest customer service to our client
- Managed $22M budget, 7 direct reports and creative plus account team of 44
- Agency leader on Genentech's Logistic Project to change materials warehouse, creating templates for reporting to ensure smooth transition
- Fostered mentorship designing new award-winning Mentoring Program still employed today at the Agency